Analyst Ratings for Redhill Biopharma (RDHL)

RDHL Rating Summary

RDHL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RDHL
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $14.30 (+1261.9%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/31/2021 Cantor Fitzgerald Brandon Folkes New Coverage Overweight
(N/A)
22.00
(N/A)
8.59
(1.05)
-87.78% Details
5/28/2021 WBB Securities Steve Brozak Downgrade Buy
(Strong Buy)
N/A
(N/A)
7.14
(1.05)
-85.29% Details
Like RDHL Ratings? Also take a look at BIOC, MCUR, BABY, VNRX

RDHL Ratings News